Alnylam Pharmaceuticals
ALNY
#651
Rank
$39.17 B
Marketcap
$293.45
Share price
0.68%
Change (1 day)
9.96%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company